Catalyst Wire Dossier Catalyst Wire Dossier

68-Gallium DOTATATE (68Ga-DOTATATE)

DOTATATE labeled with Gallium-68
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68-Gallium DOTATATE (68Ga-DOTATATE), covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. [Phase 4]

See pricing